Latest Commercialisation News

Page 69 of 116
Patrys Limited has launched a fully underwritten entitlement offer to raise approximately $1.77 million, aiming to accelerate development and commercial activities around its deoxymabs program.
Ada Torres
Ada Torres
23 July 2025
Lincoln Minerals Limited has unveiled a comprehensive update on its critical minerals projects in South Australia’s Gawler Craton, highlighting imminent drilling approvals at the Minbrie copper-base metals project and strong progress across graphite, uranium, and high purity iron assets.
Maxwell Dee
Maxwell Dee
23 July 2025
NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart technology, reporting promising clinical results in Crohn’s disease and GVHD, alongside a $3.5 million capital raise to fuel next-stage development.
Ada Torres
Ada Torres
23 July 2025
Tetratherix Limited has marked a pivotal quarter with a $25 million ASX listing, an exclusive licensing agreement with Bio Optix for ophthalmic devices, and progress on FDA regulatory submissions for its prostate spacer product.
Ada Torres
Ada Torres
23 July 2025
Sunshine Metals has launched an advanced scoping study targeting 95,000 ounces of gold and 652,000 ounces of silver at its Liontown project in North Queensland. The study aims to optimise extraction from multiple high-grade resource domains, with metallurgical test results expected in August 2025.
Maxwell Dee
Maxwell Dee
23 July 2025
Firebrick Pharma has published positive Phase 3 clinical trial results for its Nasodine nasal spray, showing efficacy against the common cold, while reporting encouraging sales growth in Singapore and the US. However, a recent capital raise fell well short of targets, casting uncertainty over its expansion plans.
Ada Torres
Ada Torres
23 July 2025
Condor Energy has secured a 12-month extension for its Technical Evaluation Agreement in Peru’s Tumbes Basin, underpinning its exploration and commercialisation plans backed by significant prospective oil and gas resources.
Maxwell Dee
Maxwell Dee
23 July 2025
Bod Science reports a solid net cash inflow of $858,000 in Q4 FY2025, driven by R&D incentives and Biortica funding, while awaiting shareholder approval to complete a key acquisition.
Ada Torres
Ada Torres
22 July 2025
Prescient Therapeutics has extended the closing date of its Share Purchase Plan to July 25, 2025, responding to shareholder demand and reinforcing strong participation. The oncology-focused biotech also highlights upcoming clinical milestones and ongoing investor engagement.
Ada Torres
Ada Torres
22 July 2025
Green Critical Minerals has commissioned its first VHD Graphite production module and secured $7 million to drive commercialisation, while its McIntosh Project delivers robust economic metrics.
Maxwell Dee
Maxwell Dee
22 July 2025
Hazer Group has forged a strategic alliance with engineering giant KBR to fast-track commercial deployment of its methane pyrolysis technology, supported by a $10.7 million capital raise and promising project developments in Japan.
Maxwell Dee
Maxwell Dee
22 July 2025
Elevate Uranium Ltd has made significant strides in its uranium exploration and development efforts, with its U-pgrade pilot plant nearing shipment and promising drilling results expanding mineralisation at key Namibian projects.
Maxwell Dee
Maxwell Dee
22 July 2025